SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-008084
Filing Date
2021-02-05
Accepted
2021-02-05 16:38:39
Documents
2
Period of Report
2021-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2248
2 EX-24 DOCUMENT attachment1.htm EX-24 3536
  Complete submission text file 0001209191-21-008084.txt   7133
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Sanna Bastiano (Reporting) CIK: 0001829069 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 21596458